Christopher Patusky, Director at UNITED THERAPEUTICS Corp (UTHR), sold 2,620 shares at $264.35 ($693K) on 2024-05-14, disclosed to the SEC on 2024-05-15.
Seasonal sale ($693k) by Director — this insider has traded UTHR in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $264.35 | 1,310 | $346K | 50.0% |
| 2 | $264.35 | 1,310 | $346K | 50.0% |
| Total | $264.35 avg | 2,620 | $693K | 100% |
| Filing → |
| UTHR | SELL | 2025-12-16 | $496K | — | Filing → |
| UTHR | SELL | 2025-03-20 | $3.0M | — | Filing → |
| UTHR | SELL | 2025-01-13 | $3.3M | — | Filing → |